Polyetherimide (PEI) pellets, with their excellent flame retardancy, dimensional stability, and biocompatibility, are becoming key materials for medical devices and 5G infrastructure. The global PEI market was valued at approximately $748 million in 2024 and is projected to reach $1.1 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.4%.
Medical-grade PEI pellets meet FDA food contact standards, ISO 10993, and USP Class VI requirements. They are compatible with various sterilization methods including steam and gamma radiation, making them widely used in surgical instruments and pharmaceutical components. In the electronics sector, their superior dielectric properties make them an ideal choice for 5G connectors and sensor housings.
As regulatory scrutiny intensifies, sourcing PEI pellets with complete certification and traceability has become a competitive necessity. Capacity expansion by Chinese manufacturers is further enriching global supply chain options.
